A carregar...

Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy

PURPOSE: Previous cohort studies have reported plasma TK1 activity (pTKa) as a potential prognostic biomarker in estrogen receptor-positive (ER+) HER2-negative (HER2−) metastatic breast cancer (MBC). In this prospective study, we report here the prognostic impact of pTKa in ER+/HER2− MBC patients tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Cabel, Luc, Rosenblum, Dan, Lerebours, Florence, Brain, Etienne, Loirat, Delphine, Bergqvist, Mattias, Cottu, Paul, Donnadieu, Anne, Bethune, Anne, Kiavue, Nicolas, Rodrigues, Manuel, Pierga, Jean-Yves, Tanguy, Marie-Laure, Bidard, François-Clément
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7489000/
https://ncbi.nlm.nih.gov/pubmed/32928264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01334-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!